HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A comparison of PCP-like compounds for NMDA antagonism in two in vivo models.

Abstract
The PCP-like compounds ketamine and dexoxadrol were evaluated in two behavioral test procedures known to be sensitive to competitive N-methyl-D-aspartate (NMDA) receptor antagonists. In the NMDA-induced convulsion test in mice, ketamine and dexoxadrol blocked convulsant activity only at doses that also induced nonspecific effects of PCP-like behaviors, thereby confounding the interpretation of results. These compounds also blocked NMDA-induced discriminative stimuli in rats; however, this effect was produced at doses lower than those which induced the nonspecific behavioral effects. These results provide evidence that in behavioral procedures, PCP-like compounds may block excitatory amino acid receptor stimulation by NMDA. The NMDA discrimination identifies these interactions without the influence of motor deficit or other behavioral motor effects.
AuthorsD A Bennett, P S Bernard, C L Amrick
JournalLife sciences (Life Sci) Vol. 42 Issue 4 Pg. 447-54 ( 1988) ISSN: 0024-3205 [Print] Netherlands
PMID2828792 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Dioxolanes
  • Dioxoles
  • Piperidines
  • Receptors, N-Methyl-D-Aspartate
  • Receptors, Neurotransmitter
  • Aspartic Acid
  • dioxadrol
  • N-Methylaspartate
  • Ketamine
  • dexoxadrol
Topics
  • Animals
  • Aspartic Acid (analogs & derivatives, antagonists & inhibitors, pharmacology)
  • Behavior, Animal (drug effects)
  • Dioxolanes (pharmacology)
  • Dioxoles (pharmacology)
  • Ketamine (pharmacology)
  • Male
  • Mice
  • Motor Activity (drug effects)
  • N-Methylaspartate
  • Piperidines (pharmacology)
  • Rats
  • Rats, Inbred Strains
  • Receptors, N-Methyl-D-Aspartate
  • Receptors, Neurotransmitter (drug effects, physiology)
  • Seizures (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: